![Charlotte Vedel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charlotte Vedel
Director/Board Member at CURASIGHT A/S
Net worth: 56 047 $ as of 2024-05-30
Profile
Charlotte Vedel is the founder of Lactobio ApS, which was founded in 2017.
She holds the title of Chief Operating Officer at Lactobio ApS.
Dr. Vedel is also the founder of Lactobio A.Dr. Vedel's current job is Deputy Chairman at Curasight A, starting in 2020.
Dr. Vedel's former jobs include Vice President-Research & Development at International N&H Denmark ApS from 2006 to 2017, Chief Technology Officer at Novo Nordisk Fonden from 2017 to 2018, and Manager-Research & Development at Roche Innovation Center Copenhagen A from 2001 to 2003.
Dr. Vedel's education includes a graduate degree from the University of Ulster and graduate and doctorate degrees from the Technical University of Denmark.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CURASIGHT A/S
0.20% | 2022-12-30 | 39,788 ( 0.20% ) | 56 047 $ | 2024-05-30 |
Charlotte Vedel active positions
Companies | Position | Start |
---|---|---|
CURASIGHT A/S | Director/Board Member | 2019-12-31 |
Lactobio ApS | Founder | 2017-07-31 |
Former positions of Charlotte Vedel
Companies | Position | End |
---|---|---|
Novo Nordisk Fonden
![]() Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Chief Tech/Sci/R&D Officer | 2017-12-31 |
International N&H Denmark ApS
![]() International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark | Chief Tech/Sci/R&D Officer | 2016-12-31 |
Roche Innovation Center Copenhagen A/S
![]() Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Chief Tech/Sci/R&D Officer | 2002-12-31 |
Training of Charlotte Vedel
Technical University of Denmark | Doctorate Degree |
University of Ulster | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CURASIGHT A/S | Health Technology |
Private companies | 4 |
---|---|
Lactobio ApS | |
Novo Nordisk Fonden
![]() Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Miscellaneous |
International N&H Denmark ApS
![]() International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark | Consumer Non-Durables |
Roche Innovation Center Copenhagen A/S
![]() Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Health Technology |
- Stock Market
- Insiders
- Charlotte Vedel